EMERAMED LTD has a total of 49 patent applications. It decreased the IP activity by 87.0%. Its first patent ever was published in 2014. It filed its patents most often in United Kingdom, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, machines and foods and drinks are NOSTRUM PHARMACEUTICALS INC, EDELSTAM INC and MATSURA YAKUGYO CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 11 | |
#2 | United States | 6 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Australia | 2 | |
#5 | Canada | 2 | |
#6 | Chile | 2 | |
#7 | China | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Mexico | 2 | |
#10 | Philippines | 2 | |
#11 | Singapore | 2 | |
#12 | South Africa | 2 | |
#13 | Brazil | 1 | |
#14 | EAPO (Eurasian Patent Organization) | 1 | |
#15 | Ecuador | 1 | |
#16 | Hungary | 1 | |
#17 | Israel | 1 | |
#18 | Morocco | 1 | |
#19 | Montenegro | 1 | |
#20 | Peru | 1 | |
#21 | Serbia | 1 | |
#22 | Ukraine | 1 | |
#23 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Foods and drinks | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Climate change adaptation technologies | |
#5 | Special foods | |
#6 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Haley Boyd Eugene | 32 |
#2 | Klingberg Ragnar Axel Theodor | 32 |
#3 | Ragnar Axel Theodor Klingberg | 3 |
#4 | Boyd Eugene Haley | 3 |
#5 | Haley Boyd E | 2 |
#6 | Theodor Klingberg Ragnar Axel | 1 |
#7 | Eugene Haley Boyd | 1 |
Publication | Filing date | Title |
---|---|---|
GB202014420D0 | New pharmaceutical use | |
GB202013014D0 | New medical uses | |
GB202005057D0 | New Use | |
GB201913328D0 | New Pharmaceutical use | |
GB201911870D0 | New medical uses | |
GB201814520D0 | New pharmaceutical use | |
GB201813217D0 | New medical uses | |
GB201714295D0 | New pharamaceutical use | |
GB201712992D0 | New medical uses | |
CA3032858A1 | New use of n,n-bis-2-mercaptoethyl isophthalamide | |
GB201704107D0 | New medical uses | |
GB201702051D0 | New Pharmaceutical use | |
US2017202791A1 | N,n-bis-2-mercaptoethyl isophthalamide for the treatment of neurodegenerative diseases | |
KR20160140929A | New use of n,n-bis-2-mercaptoethyl isophthalamide | |
US2015265556A1 | Method of supplementing the diet and ameliorating oxidative stress |